Experimental immune cell therapy tested for aggressive breast cancer
NCT ID NCT06347068
Summary
This early-stage study is testing the safety of a new type of treatment called CAR-T cell therapy for adults with triple negative breast cancer that has returned or stopped responding to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to better target cancer, and then infuse them back into the body. The main goal is to find a safe dose and understand side effects before testing if it effectively fights the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of North Carolina
RECRUITINGChapel Hill, North Carolina, 27599, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.